Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage

Retraction in: /10.3892/etm.2024.12697
  • Authors:
    • Fei Teng
    • Yanxin Yin
    • Jia Guo
    • Ming Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, Biomedical Research Center of Tongji University Suzhou Institute, Suzhou, Jiangsu 215101, P.R. China
    Copyright: © Teng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2433-2440
    |
    Published online on: February 10, 2020
       https://doi.org/10.3892/etm.2020.8510
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Calpain activation may have an important role in early brain injury (EBI) following subarachnoid hemorrhage (SAH). The present study investigated the effects of the calpastatin peptide, a cell‑permeable peptide that functions as a potent inhibitor of calpain, on EBI in a rat SAH model. It was revealed that calpastatin peptide treatment significantly reduced SAH‑induced body weight loss and neurological deficit at 72 h when compared with untreated SAH controls. Furthermore, the quantification of brain water content and the extravasation of Evans blue dye revealed a significant reduction in SAH‑induced brain edema and blood‑brain barrier permeability at 72 h due to treatment with the calpastatin peptide when compared with untreated SAH controls. Finally, calpastatin peptide treatment significantly attenuated the protein levels of Bax, cytochrome c, cleaved caspase‑9 and cleaved caspase‑3, and reduced the number of terminal deoxynucleotidyl transferase dUTP nick end labelling‑positive cells in the basal cortex at 72 h after SAH when compared with untreated SAH controls. These results indicated that the calpastatin peptide may ameliorate EBI following SAH in rat models.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Sehba FA, Hou J, Pluta RM and Zhang JH: The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 97:14–37. 2012.PubMed/NCBI View Article : Google Scholar

2 

Kooijman E, Nijboer CH, van Velthoven CT, Kavelaars A, Kesecioglu J and Heijnen CJ: The rodent endovascular puncture model of subarachnoid hemorrhage: Mechanisms of brain damage and therapeutic strategies. J Neuroinflammation. 11(2)2014.PubMed/NCBI View Article : Google Scholar

3 

Kikkawa Y, Kurogi R and Sasaki T: The single and double blood injection rabbit subarachnoid hemorrhage model. Transl Stroke Res. 6:88–97. 2015.PubMed/NCBI View Article : Google Scholar

4 

Marbacher S, Grüter B, Schöpf S, Croci D, Nevzati E, D'Alonzo D, Lattmann J, Roth T, Bircher B, Wolfert C, et al: Systematic review of in vivo animal models of subarachnoid hemorrhage: Species, standard parameters, and outcomes. Transl Stroke Res. Sep 12, 2018.(Epub ahead of print). PubMed/NCBI View Article : Google Scholar

5 

Miller BA, Turan N, Chau M and Pradilla G: Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int. 2014(384342)2014.PubMed/NCBI View Article : Google Scholar

6 

de Oliveira Manoel AL and Macdonald RL: Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol. 9(292)2018.PubMed/NCBI View Article : Google Scholar

7 

Lad SP, Hegen H, Gupta G, Deisenhammer F and Steinberg GK: Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 21:30–41. 2012.PubMed/NCBI View Article : Google Scholar

8 

Lewis SB, Velat GJ, Miralia L, Papa L, Aikman JM, Wolper RA, Firment CS, Liu MC, Pineda JA, Wang KK and Hayes RL: Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: A novel biomarker of proteolytic injury. J Neurosurg. 107:792–796. 2007.PubMed/NCBI View Article : Google Scholar

9 

Siman R, Giovannone N, Toraskar N, Frangos S, Stein SC, Levine JM and Kumar MA: Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS One. 6(e28938)2011.PubMed/NCBI View Article : Google Scholar

10 

Papa L, Rosenthal K, Silvestri F, Axley JC, Kelly JM and Lewis SB: Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage. Sci Rep. 8(13308)2018.PubMed/NCBI View Article : Google Scholar

11 

Wang W, Han P, Xie R, Yang M, Zhang C, Mi Q, Sun B and Zhang Z: TAT-mGluR1 attenuation of neuronal apoptosis through Prevention of MGluR1α truncation after experimental subarachnoid hemorrhage. ACS Chem Neurosci. 10:746–756. 2018.PubMed/NCBI View Article : Google Scholar

12 

Czogalla A and Sikorski AF: Spectrin and calpain: A ‘target’ and a ‘sniper’ in the pathology of neuronal cells. Cell Mol Life Sci. 62:1913–1924. 2005.PubMed/NCBI View Article : Google Scholar

13 

Zhou YD and Cai L: Calpeptin reduces neurobehavioral deficits and neuronal apoptosis following subarachnoid hemorrhage in rats. J Stroke Cerebrovasc Dis. 28:125–132. 2019.PubMed/NCBI View Article : Google Scholar

14 

Cheng SY, Wang SC, Lei M, Wang Z and Xiong K: Regulatory role of calpain in neuronal death. Neural Regen Res. 13:556–562. 2018.PubMed/NCBI View Article : Google Scholar

15 

Goll DE, Thompson VF, Li H, Wei W and Cong J: The calpain system. Physiol Rev. 83:731–801. 2003.PubMed/NCBI View Article : Google Scholar

16 

Germanò A, Costa C, DeFord SM, Angileri FF, Arcadi F, Pike BR, Bramanti P, Bausano B, Zhao X, Day AL, et al: Systemic administration of a calpain inhibitor reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma. 19:887–896. 2002.PubMed/NCBI View Article : Google Scholar

17 

Wendt A, Thompson VF and Goll DE: Interaction of calpastatin with calpain: a review. Biol Chem. 385:465–472. 2004.PubMed/NCBI View Article : Google Scholar

18 

National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press (US), Washington, DC, 2011.

19 

Sugawara T, Ayer R, Jadhav V and Zhang JH: A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 167:327–334. 2008.PubMed/NCBI View Article : Google Scholar

20 

Zhang ZY, Jiang M, Fang J, Yang MF, Zhang S, Yin YX, Li DW, Mao LL, Fu XY, Hou YJ, et al: Enhanced therapeutic potential of nano-curcumin against subarachnoid hemorrhage-induced blood-brain barrier disruption through inhibition of inflammatory response and oxidative stress. Mol Neurobiol. 54:1–14. 2017.PubMed/NCBI View Article : Google Scholar

21 

Zhang ZY, Sun BL, Liu JK, Yang MF, Li DW, Fang J, Zhang S, Yuan QL and Huang SL: Activation of mGluR5 attenuates microglial activation and neuronal apoptosis in early brain injury after experimental subarachnoid hemorrhage in rats. Neurochem Res. 40:1121–1132. 2015.PubMed/NCBI View Article : Google Scholar

22 

Wu Q, Qi L, Li H, Mao L, Yang M, Xie R, Yang X, Wang J, Zhang Z, Kong J and Sun B: Roflumilast reduces cerebral inflammation in a rat model of experimental subarachnoid hemorrhage. Inflammation. 40:1245–1253. 2017.PubMed/NCBI View Article : Google Scholar

23 

Fan LF, He PY, Peng YC, Du QH, Ma YJ, Jin JX, Xu HZ, Li JR, Wang ZJ, Cao SL, et al: Mdivi-1 ameliorates early brain injury after subarachnoid hemorrhage via the suppression of inflammation-related blood-brain barrier disruption and endoplasmic reticulum stress-based apoptosis. Free Radic Biol Med. 112:336–349. 2017.PubMed/NCBI View Article : Google Scholar

24 

Yildiz-Unal A, Korulu S and Karabay A: Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis Treat. 11:297–310. 2015.PubMed/NCBI View Article : Google Scholar

25 

Feng D, Wang W, Dong Y, Wu L, Huang J, Ma Y, Zhang Z, Wu S, Gao G and Qin H: Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway. Neuroscience. 268:21–32. 2014.PubMed/NCBI View Article : Google Scholar

26 

Schubert GA, Poli S, Mendelowitsch A, Schilling L and Thome C: Hypothermia reduces early hypoperfusion and metabolic alterations during the acute phase of massive subarachnoid hemorrhage: A laser-Doppler-flowmetry and microdialysis study in rats. J Neurotrauma. 25:539–548. 2008.PubMed/NCBI View Article : Google Scholar

27 

Wu CT, Wen LL, Wong CS, Tsai SY, Chan SM, Yeh CC, Borel CO and Cherng CH: Temporal changes in glutamate, glutamate transporters, basilar arteries wall thickness, and neuronal variability in an experimental rat model of subarachnoid hemorrhage. Anesth Analg. 112:666–673. 2011.PubMed/NCBI View Article : Google Scholar

28 

Zhang Z, Liu J, Fan C, Mao L, Xie R, Wang S, Yang M, Yuan H, Yang X, Sun J, et al: The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced neuroprotection in a rat subarachnoid hemorrhage model. Exp Neurol. 301:13–25. 2018.PubMed/NCBI View Article : Google Scholar

29 

Yamaura I, Tani E, Saido TC, Suzuki K, Minami N and Maeda Y: Calpain-calpastatin system of canine basilar artery in vasospasm. J Neurosurg. 79:537–543. 1993.PubMed/NCBI View Article : Google Scholar

30 

Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L and Allen H: Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys. 356:187–196. 1998.PubMed/NCBI View Article : Google Scholar

31 

Rami A, Volkmann T, Agarwal R, Schoninger S, Nürnberger F, Saido TC and Winckler J: beta2-Adrenergic receptor responsiveness of the calpain-calpastatin system and attenuation of neuronal death in rat hippocampus after transient global ischemia. Neurosci Res. 47:373–382. 2003.PubMed/NCBI View Article : Google Scholar

32 

Feng D, Wang B, Ma Y, Shi W, Tao K, Zeng W, Cai Q, Zhang Z and Qin H: The Ras/Raf/Erk pathway mediates the subarachnoid hemorrhage-induced Apoptosis of hippocampal neurons through phosphorylation of p53. Mol Neurobiol. 53:5737–5748. 2016.PubMed/NCBI View Article : Google Scholar

33 

Hong Y, Shao A, Wang J, Chen S, Wu H, McBride DW, Wu Q, Sun X and Zhang J: Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: Possible role of the Akt/GSK3β signaling pathway. PLoS One. 9(e96212)2014.PubMed/NCBI View Article : Google Scholar

34 

Gao G and Dou QP: N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem. 80:53–72. 2000.PubMed/NCBI View Article : Google Scholar

35 

Boehmerle W and Endres M: Salinomycin induces calpain and cytochrome c-mediated neuronal cell death. Cell Death Dis. 2(e168)2011.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Teng F, Yin Y, Guo J and Jiang M: Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697. Exp Ther Med 19: 2433-2440, 2020.
APA
Teng, F., Yin, Y., Guo, J., & Jiang, M. (2020). Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697. Experimental and Therapeutic Medicine, 19, 2433-2440. https://doi.org/10.3892/etm.2020.8510
MLA
Teng, F., Yin, Y., Guo, J., Jiang, M."Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697". Experimental and Therapeutic Medicine 19.4 (2020): 2433-2440.
Chicago
Teng, F., Yin, Y., Guo, J., Jiang, M."Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2433-2440. https://doi.org/10.3892/etm.2020.8510
Copy and paste a formatted citation
x
Spandidos Publications style
Teng F, Yin Y, Guo J and Jiang M: Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697. Exp Ther Med 19: 2433-2440, 2020.
APA
Teng, F., Yin, Y., Guo, J., & Jiang, M. (2020). Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697. Experimental and Therapeutic Medicine, 19, 2433-2440. https://doi.org/10.3892/etm.2020.8510
MLA
Teng, F., Yin, Y., Guo, J., Jiang, M."Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697". Experimental and Therapeutic Medicine 19.4 (2020): 2433-2440.
Chicago
Teng, F., Yin, Y., Guo, J., Jiang, M."Calpastatin peptide attenuates early brain injury following experimental subarachnoid hemorrhage Retraction in /10.3892/etm.2024.12697". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2433-2440. https://doi.org/10.3892/etm.2020.8510
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team